Joseph J. Larosa

At a glance: Joseph J. Larosa is General Counsel at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Nov 4, 2026, reported a sale of $3.8M. On file: 0 purchase lines ($0) and 2 sale lines ($4.3M).

Disclosed holdings: about $37.2M of REGN stock: 38,906 shares reported on their latest Form 4 (filed Nov 4, 2026), valued at the Nov 13, 2026 close of $955.47. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

General Counsel at Regeneron Pharmaceuticals, Inc. (REGN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—

Avg. 90-day return—

vs. S&P 500—

Beat the market—

Paper profit on buys$0

Total bought / sold$0 / $4.3M

Reported trades

Filed	Stock	Type	Shares	Price	Value	Since
Nov 4SEC	REGNRegeneron Pharmaceuticals, Inc.	Sell	3,93939,433 held (−9%)	$965.41	$3.8M	-1.0%
Nov 4SEC	REGNRegeneron Pharmaceuticals, Inc.	Sell	52738,906 held (−1%)	$966.11	$509K	-1.1%

Follow Joseph J. Larosa

Get one email when Joseph J. Larosa files a new purchase or sale. Free.

At most one email a day about Joseph J. Larosa, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.